Wysing Arts Centre, Cambridge, UK
Ophiux gives a glimpse into a near future that whilst fictional, is not far from reality and is founded on current scientific research. The work imagines a future in which synthetic biology has been fully realized and applied to both advance human evolution and increase life expectancy, and where human biology has been computer programmed. The installation includes a film work and a ‘futuristic medical room’.
To conceive the exhibition, Holder worked in close collaboration with scientists she met during her residency at Wysing in 2015 - Dr Marco Galardini, a Computational Biologist at the European Bioinformatics Institute at the Wellcome Trust Genome Campus, Cambridge, and Dr Katrin Linse, Senior Biodiversity Biologist at the British Antarctic Survey, Cambridge.
Ophiux visualizes how current digital developments are used to extract data from DNA. The exhibition proposes that in the future the human population, and millions of other organisms, will have been genetically sequenced in order to extract data, with the aim of furthering life. Holder’s work reflects on the reality of today’s healthcare, in which our bodies are increasingly mapped and digitized.
The installation includes larger than life-sized models of biological imaging machines as well as genetic sequencing equipment. It simulates not only the collection of data from our own bodies but also the sampling of data from other organisms by a speculative pharmaceutical company: ‘Ophiux’
Ophiux is located across two sites at Wysing Arts Centre, with the main installation in the gallery and the film presented in the open studio. The film has been co-commissioned by Deptford X where it premiered at their festival in September 2016, followed by a tour to Sonic Acts, The Noise of Being exhibition in Amsterdam and other arts and science venues to be announced at a later date.
The exhibition was made possible with a generous grant from the Arts Council England.
Very special thanks to AJA (sound design) and Alex Walker (graphic Design).